FDAnews
www.fdanews.com/articles/205746-euformatics-genomic-software-omnomicsngs-gets-ce-ivd-mark

Euformatics’ Genomic Software omnomicsNGS Gets CE-IVD Mark

December 13, 2021

Euformatics’s genomic variant interpretation and reporting software tool, omnomicsNGS, has been granted a CE-IVD mark.

The software, which is available as a cloud-based installation or for installing locally on the customer’s hardware, is primarily designed for clinical use.

OmnomicsNGS provides flexibility and security to clinical users of next-generation sequencing (NGS) data, whatever their set-up, the Helsinki, Finland-based company said. 

View today's stories